AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Digene (Gaithersburg, Maryland) said it has signed a three-year agreement with Quest Diagnostics (Teterboro, New Jersey).(Agreements)
* Digene (Gaithersburg, Maryland) said it has signed a three-year agreement with Quest Diagnostics (Teterboro, New Jersey) under which the nation's largest commercial testing laboratory will offer its physician clients high-risk HPV DNA testing for routine cervical cancer screening in women 30 years of age and older, in conjunction with the Pap test.
Under the agreement, Quest Diagnostics will expand the products and services it offers, and upon which it educates physicians, to include this added use for the Digene test, which detects high-risk types of human papillomavirus (HPV)--the cause of most cervical cancers. Previously, Quest Diagnostics had provided the test…
- Parexel International (Waltham, Massachusetts), a worldwide biopharmaceutical...
- Newspaper article from: Diagnostics & Imaging Week February 6, 2003 700+ words
...outsourcing company, and Quest Diagnostics Creterboro, New Jersey) ) a provider of diagnostic...in which Parexel and Quest Diagnostics Clinical Trials will...companies worldwide. Quest Diagnostics Clinical Trials provides...
- Quest Diagnostics (Lyndhurst, New Jersey) reported that it has been awarded a...
- Newspaper article from: Diagnostics & Imaging Week March 29, 2007 700+ words
In contract news, Quest Diagnostics (Lyndhurst, New Jersey) reported that it has been awarded a five-year...pathologists, who will also have the ability to consult with Quest Diagnostics' more than 500 MDs and PhDs in the U.S. The agreement...
- TriPath Imaging (Burlington, North Carolina) said it has entered into a...
- Newspaper article from: Diagnostics & Imaging Week March 13, 2003 700+ words
...it has entered into a collaboration with Quest Diagnostics (Teterboro, New Jersey), a provider of diagnostic laboratory testing...services. Under terms of the agreement, Quest Diagnostics will begin offering TriPath's 13 Series...
- Quest Diagnostics (Lyndhurst, New Jersey), a provider of diagnostic testing,...
- Newspaper article from: Diagnostics & Imaging Week June 7, 2007 700+ words
Quest Diagnostics (Lyndhurst, New Jersey), a provider of diagnostic testing, reported that it plans to complete its previously disclosed $2 billion acquisition of AmeriPath...
- Quest Diagnostics (Lyndhurst, New Jersey), one of the nation's largest...
- Newspaper article from: Diagnostics & Imaging Week June 7, 2007 700+ words
Quest Diagnostics (Lyndhurst, New Jersey), one of the nation's largest providers of diagnostics testing, information and services, reported the determination of pricing...
- Quest Diagnostics (Teterboro, New Jersey), a provider of diagnostic testing,...
- Newspaper article from: Diagnostics & Imaging Week January 2, 2003 700+ words
* Quest Diagnostics (Teterboro, New Jersey), a provider of diagnostic testing, information and services, has extended the expiration date for its previously announced...
- Quest Diagnostics (Teterboro, New Jersey) said that it has begun to offer a...
- Newspaper article from: The BBI Newsletter September 1, 2003 700+ words
* Quest Diagnostics (Teterboro, New Jersey) said that it has begun to offer a test to enable physicians to detect a new risk factor for cardiovascular disease by measuring...
- Quest Diagnostics (Teterboro, New Jersey) said its test manufacturing unit....
- Newspaper article from: The BBI Newsletter February 1, 2002 700+ words
* Quest Diagnostics (Teterboro, New Jersey) said its test manufacturing unit, Nichols Institute Diagnostics (San Juan Capistrano, California), received FDA clearance...
- Quest Diagnostics (Teterboro, New Jersey), a provider of diagnostic testing and...
- Newspaper article from: Diagnostics & Imaging Week October 24, 2002 700+ words
* Quest Diagnostics (Teterboro, New Jersey), a provider of diagnostic testing and services, introduced its CF Complete test at the annual meeting of the American Society...
- Quest Diagnostics (Lyndhurst, New Jersey) reported that it has licensed rights...
- Newspaper article from: Diagnostics & Imaging Week February 21, 2008 700+ words
* Quest Diagnostics (Lyndhurst, New Jersey) reported that it has licensed rights to uses of the Septin 9 DNA methylation biomarker from Epigenomics (Berlin) to develop...
Source: HighBeam Research, Digene (Gaithersburg, Maryland) said it has signed a three-year...
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
